Dr. Mower was a cardiologist at Baltimore-based Sinai Hospital from 1966 to 1989, where he held various leadership positions. He developed the groundbreaking automatic implantable cardioverter defibrillator, credited with saving hundreds of thousands of patients’ lives, with Michel Mirowski, MD, a Sinai colleague.
“He continued his research and worked up until his death,” his son Mark Mower, told the Baltimore Sun in an email. “He never wanted to waste a moment of his life. Recently, he formed Rocky Mountain Biphasic, a biomedical company, to exploit a portfolio of his newest scientific patents. His newest research has applications in diabetes, wound healing, COVID, cardiology and more. Mort’s legacy and groundbreaking science will continue.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
